News

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.
A new treatment for atrial fibrillation may change the future for millions. A new procedure called pulse field ablation is a ...
A bill banning the distribution of abortion pills recently passed through the Texas Senate. Implications in the bill's text about power balances have some Texas lawmakers worried. Monday saw a ...
For patients with HIV and atrial fibrillation ... regarding potential drug-drug interactions between oral anticoagulants and antiretroviral therapy. Apixaban is currently the most prescribed ...
This medication is an anticoagulant ... who have no problems with their heart valve (nonvalvular atrial fibrillation). When should Apixaban not be taken? (Contraindications) Contraindicated ...
Apixaban is a non-vitamin K oral anticoagulant used to treat non-valvular atrial fibrillation to lower the ... Below are the known drug interactions of NOACs: P-glycoprotein (P-gp) inhibitors ...
apixaban in patients with atrial fibrillation despite less bleeding ... “Importantly, that may speak to the dose of the drug used in this study and may speak to how much activity inhibition ...
Effective atrial fibrillation (AFib ... or direct oral anticoagulants, such as apixaban or dabigatran, to prevent blood clots and reduce stroke risk. Read more about medications for AFib.
Very elderly people with nonvalvular atrial fibrillation (Afib) got the same stroke prevention benefits from edoxaban (Savaysa) and apixaban (Eliquis), though one drug was associated with more ...
The oral anticoagulant medication ... conducted the largest and longest-running study of apixaban for people with device-detected atrial fibrillation. The study involved more than 4,000 ...
did not receive at least one dose of a trial medication. Apixaban or aspirin was permanently discontinued during follow-up owing to the development of subclinical atrial fibrillation lasting more ...